BusinessThe American Health Council Names Paul Aoun, DO/PhD, to Board of PhysiciansBy Nasdaq OMXJul 19, 2017, 12:00 PM UTC
BusinessCrownBio Demonstrates Scientific Advancements in Metabolic Disease with a validated and improved translatable model for obesity and Type 2 Diabetes drug discoveryBy Nasdaq OMXJul 6, 2017, 12:00 PM UTC
BusinessSolera Health Further Bolsters Executive Management Team with Appointment of Brian Esterly as Chief Operating OfficerBy Nasdaq OMXJun 28, 2017, 2:00 PM UTC
BusinessWellDoc® Provides BlueStar® to New Class in American Diabetes Association of Maryland’s “The Fabulous YOU!” ProgramBy Nasdaq OMXJun 27, 2017, 1:00 PM UTC
BusinessXeris Pharmaceuticals Announces New Results From Ready-To-Use Liquid Glucagon Clinical Development ProgramBy Nasdaq OMXJun 16, 2017, 11:51 AM UTC
BusinessProLynx announces PLX039, a hydrogel-microsphere drug delivery system that supports once-monthly administration of a GLP-1 receptor agonistBy Nasdaq OMXJun 12, 2017, 1:00 PM UTC
BusinessLyfebulb and Novo Nordisk team up again to advance entrepreneur innovation in diabetes managementBy Nasdaq OMXJun 7, 2017, 11:00 AM UTC
